1-3 of 3
Andrea Biondo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ASTX295 a Novel Potent MDM2 Antagonist Induces More Than One Mechanism of Programmed Cell Death (PCD) in Lymphoid Malignancies

Nishat Iqbal, Sandrine Jayne, Harriet S. Walter, Andrea Biondo, Martin Sims, Maria Ahn, Martin J.S. Dyer
Journal: Blood
Blood (2024) 144 (Supplement 1): 3591.
https://doi.org/10.1182/blood-2024-206110
Published: 2024
Journal Articles

Epigenetic Priming By Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-Cell Lymphoma

George Ward, Zhiqiang Zhang, Simone Jueliger, Ilya Potapov, Matthew P Davis, Adam Boxall, Jason A Taylor, Harold N. Keer, Andrea Biondo, John F Lyons, Martin Sims, Tomoko Smyth
Journal: Blood
Blood (2023) 142 (Supplement 1): 1439.
https://doi.org/10.1182/blood-2023-186712
Published: 2023
Journal Articles

Combining the IAP Antagonist Tolinapant with a DNA Hypomethylating Agent Enhances Immunogenic Cell Death in Preclinical Models of T-Cell Lymphoma

George A. Ward, Simone Jueliger, Martin Sims, Matthew Davis, Adam Boxall, Harpreet Saini, Jason A. Taylor, Andrea Biondo, John F. Lyons, Tomoko Smyth
Journal: Blood
Blood (2021) 138 (Supplement 1): 3986.
https://doi.org/10.1182/blood-2021-152176
Published: 2021